Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.280
-0.010 (-0.78%)
At close: Mar 9, 2026, 4:00 PM EDT
1.250
-0.030 (-2.34%)
After-hours: Mar 9, 2026, 6:29 PM EDT
Revelation Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5 | 5 | 4 | 3 | 4 | 66 | |
| Market Cap Growth | 19.56% | 22.99% | 22.21% | -29.09% | -93.24% | -29.40% | |
| Enterprise Value | -5 | -8 | -3 | -11 | -2 | 69 | |
| Last Close Price | 1.29 | 3.20 | 88.51 | 2884.04 | 38324.29 | 2056327.24 | |
| PB Ratio | 0.23 | 0.54 | 0.82 | 0.47 | 4.22 | -661.53 | |
| P/TBV Ratio | 0.53 | 0.54 | 0.82 | 0.47 | 4.22 | - | |
| Debt / Equity Ratio | 0.08 | 0.08 | - | - | - | -0.17 | |
| Net Debt / Equity Ratio | -1.13 | -1.13 | -1.38 | -1.80 | -4.99 | 12.65 | |
| Net Debt / EBITDA Ratio | 1.11 | 1.11 | 0.82 | 1.39 | 0.49 | 0.11 | |
| Net Debt / FCF Ratio | 1.21 | 1.21 | 0.35 | 1.65 | 0.47 | 0.11 | |
| Quick Ratio | 5.38 | 5.38 | 3.40 | 2.15 | 1.18 | 0.60 | |
| Current Ratio | 5.41 | 5.41 | 3.43 | 2.18 | 1.22 | 0.89 | |
| Return on Equity (ROE) | -131.38% | -131.38% | -264.85% | -3.12% | -2272.77% | -723.81% | |
| Return on Assets (ROA) | -62.28% | -62.28% | -52.93% | -61.08% | -179.98% | -224.21% | |
| Return on Capital Employed (ROCE) | -94.60% | -94.60% | -169.40% | -130.20% | -1032.30% | 12014.20% | |
| Earnings Yield | -314.61% | -188.13% | -390.38% | -3.82% | -243.60% | -18.22% | |
| FCF Yield | -175.02% | -174.53% | -476.09% | -231.14% | -252.37% | -17.05% | |
| Buyback Yield / Dilution | -4243.28% | -4243.28% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.